Cargando…
D-Amino Acids as a Biomarker in Schizophrenia
D-amino acids may play key roles for specific physiological functions in different organs including the brain. Importantly, D-amino acids have been detected in several neurological disorders such as schizophrenia, amyotrophic lateral sclerosis, and age-related disorders, reflecting the disease condi...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883943/ https://www.ncbi.nlm.nih.gov/pubmed/35225861 http://dx.doi.org/10.3390/diseases10010009 |
_version_ | 1784660050769346560 |
---|---|
author | Taniguchi, Kurumi Sawamura, Haruka Ikeda, Yuka Tsuji, Ai Kitagishi, Yasuko Matsuda, Satoru |
author_facet | Taniguchi, Kurumi Sawamura, Haruka Ikeda, Yuka Tsuji, Ai Kitagishi, Yasuko Matsuda, Satoru |
author_sort | Taniguchi, Kurumi |
collection | PubMed |
description | D-amino acids may play key roles for specific physiological functions in different organs including the brain. Importantly, D-amino acids have been detected in several neurological disorders such as schizophrenia, amyotrophic lateral sclerosis, and age-related disorders, reflecting the disease conditions. Relationships between D-amino acids and neurophysiology may involve the significant contribution of D-Serine or D-Aspartate to the synaptic function, including neurotransmission and synaptic plasticity. Gut-microbiota could play important roles in the brain-function, since bacteria in the gut provide a significant contribution to the host pool of D-amino acids. In addition, the alteration of the composition of the gut microbiota might lead to schizophrenia. Furthermore, D-amino acids are known as a physiologically active substance, constituting useful biomarkers of several brain disorders including schizophrenia. In this review, we wish to provide an outline of the roles of D-amino acids in brain health and neuropsychiatric disorders with a focus on schizophrenia, which may shed light on some of the superior diagnoses and/or treatments of schizophrenia. |
format | Online Article Text |
id | pubmed-8883943 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88839432022-03-01 D-Amino Acids as a Biomarker in Schizophrenia Taniguchi, Kurumi Sawamura, Haruka Ikeda, Yuka Tsuji, Ai Kitagishi, Yasuko Matsuda, Satoru Diseases Review D-amino acids may play key roles for specific physiological functions in different organs including the brain. Importantly, D-amino acids have been detected in several neurological disorders such as schizophrenia, amyotrophic lateral sclerosis, and age-related disorders, reflecting the disease conditions. Relationships between D-amino acids and neurophysiology may involve the significant contribution of D-Serine or D-Aspartate to the synaptic function, including neurotransmission and synaptic plasticity. Gut-microbiota could play important roles in the brain-function, since bacteria in the gut provide a significant contribution to the host pool of D-amino acids. In addition, the alteration of the composition of the gut microbiota might lead to schizophrenia. Furthermore, D-amino acids are known as a physiologically active substance, constituting useful biomarkers of several brain disorders including schizophrenia. In this review, we wish to provide an outline of the roles of D-amino acids in brain health and neuropsychiatric disorders with a focus on schizophrenia, which may shed light on some of the superior diagnoses and/or treatments of schizophrenia. MDPI 2022-01-31 /pmc/articles/PMC8883943/ /pubmed/35225861 http://dx.doi.org/10.3390/diseases10010009 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Taniguchi, Kurumi Sawamura, Haruka Ikeda, Yuka Tsuji, Ai Kitagishi, Yasuko Matsuda, Satoru D-Amino Acids as a Biomarker in Schizophrenia |
title | D-Amino Acids as a Biomarker in Schizophrenia |
title_full | D-Amino Acids as a Biomarker in Schizophrenia |
title_fullStr | D-Amino Acids as a Biomarker in Schizophrenia |
title_full_unstemmed | D-Amino Acids as a Biomarker in Schizophrenia |
title_short | D-Amino Acids as a Biomarker in Schizophrenia |
title_sort | d-amino acids as a biomarker in schizophrenia |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883943/ https://www.ncbi.nlm.nih.gov/pubmed/35225861 http://dx.doi.org/10.3390/diseases10010009 |
work_keys_str_mv | AT taniguchikurumi daminoacidsasabiomarkerinschizophrenia AT sawamuraharuka daminoacidsasabiomarkerinschizophrenia AT ikedayuka daminoacidsasabiomarkerinschizophrenia AT tsujiai daminoacidsasabiomarkerinschizophrenia AT kitagishiyasuko daminoacidsasabiomarkerinschizophrenia AT matsudasatoru daminoacidsasabiomarkerinschizophrenia |